Possible role of rivoglitazone thiazolidine class of drug as dual-target therapeutic agent for bacterial infections: An in silico study
Clicks: 283
ID: 78147
2019
| Reference Key |
yele2019possiblemedical
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Yele, V. |
| Journal | medical hypotheses |
| Year | 2019 |
| DOI | 10.1016/j.mehy.2019.109305 |
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.